Valuation: Embecta Corp.

Market Cap 351M 315M 287M 262M 494M 32.97B 510M 3.47B 1.38B 17.59B 1.32B 1.29B 55.53B P/E 2026 *
5.23x
P/E 2027 * 4.49x
Enterprise Value 351M 315M 287M 262M 494M 32.97B 510M 3.47B 1.38B 17.59B 1.32B 1.29B 55.53B EV / Sales 2026 *
0.34x
EV / Sales 2027 * 0.32x
Free-Float
97.99%
Yield 2026 *
4.07%
Yield 2027 * 0.65%
1 day-2.21%
1 week-0.96%
Current month-0.96%
1 month+7.65%
3 months+40.05%
6 months+70.05%
Current year-47.90%
1 week 5.78
Extreme 5.78
6.79
1 month 5.77
Extreme 5.77
6.9
Current year 2.77
Extreme 2.77
13.44
1 year 2.77
Extreme 2.77
14.91
3 years 2.77
Extreme 2.77
21.48
5 years 0
Extreme 0
49
10 years 0
Extreme 0
49
Manager TitleAgeSince
Chief Executive Officer 58 2022-03-21
Director of Finance/CFO 53 2022-03-21
Investor Relations Contact - 2022-05-31
Director TitleAgeSince
Chairman 58 2026-02-10
Director/Board Member 60 2022-03-19
Director/Board Member 58 2022-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Sell

Director

-6,293 0.0111%
8/12/26 Buy

General Counsel

20,000 0.0337%
8/12/26 Buy

Chief Financial Officer

20,000 0.0337%
Change 5-day change 1-year change 3-year change Capi.($)
-2.21%-0.96%-55.11%-59.67% 351M
-3.23%+3.51%-13.00%+16.03% 190B
-2.90%+5.45%+10.41%+41.96% 125B
-2.75%+11.65%-8.47%+18.59% 124B
+0.96%+5.15%-37.16%+11.38% 99.31B
-1.80%+0.82%-7.52%+69.50% 63.65B
-0.78%+7.07%+19.14%-17.21% 57.71B
+0.79%+22.65%-4.57%+58.05% 53.26B
+3.44%-6.58%-7.42%+48.37% 47.03B
-2.36%+3.72%+3.86%-7.32% 36.15B
Average -1.09%+4.45%-9.98%+17.97% 79.65B
Weighted average by Cap. -1.59%+5.55%-7.24%+25.40%

Financials

2026 *2027 *
Net sales 1.02B 919M 840M 767M 1.44B 96.3B 1.49B 10.12B 4.04B 51.39B 3.85B 3.76B 162B 1.08B 970M 887M 809M 1.53B 102B 1.57B 10.69B 4.26B 54.26B 4.06B 3.97B 171B
Net income 69.3M 62.16M 56.8M 51.85M 97.7M 6.51B 101M 685M 273M 3.48B 260M 255M 10.97B 76.83M 68.91M 62.98M 57.49M 108M 7.22B 112M 759M 303M 3.85B 288M 282M 12.17B
Net Debt - -
Projected Income Statement - Annual - Embecta Corp.
Logo Embecta Corp.
Embecta Corp. is a global medical device company. It provides solutions to improve the health and well-being of people living with diabetes. Its portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through channels, including retail, hospitals and pharmacies. It is also a manufacturer of medical devices and drug delivery technologies.
Employees
1,850
Date Price Change Volume
26-11-06 US$6.190 -2.21% 623,134
26-11-05 US$6.330 -2.91% 780,109
26-11-04 US$6.520 +7.24% 1,153,754
26-11-03 US$6.080 -1.78% 570,290
26-11-02 US$6.190 -0.96% 658,223
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Embecta Corp.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
6.190USD
Average target price
4.000USD
Spread / Average Target
-35.38%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Embecta Corp.
  1. Stock Market
  2. Stocks
  3. EMBC Stock